PAR 5.13% 20.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-1555

  1. 737 Posts.
    lightbulb Created with Sketch. 140
    Gosh, can't believe anyone would publish such a nonsense argument.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.